-
Mashup Score: 1The History of Obesity Research - 2 year(s) ago
Perhaps the most unexpected development in pediatric endocrinology in the past 50 years has been the recognition of obesity as an endocrine/metabolic disorder rather than a life choice or moral failing. The history of obesity research is disjointed, having followed two separate paths in the 20th century, based on two independent yet overlapping par
Source: www.karger.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Carcinoid Heart Disease-Induced Right-Sided Heart Failure as a Culprit for Significant Ascites - 2 year(s) ago
The diagnosis of carcinoid heart disease as a cause of ascites can be hard to establish. We report a patient with well-differentiated neuroendocrine neoplasm of the liver who presented with high serum ascites albumin gradient and high protein ascites due to carcinoid heart disease (CHD). As ascites caused by CHD are rare, the etiology can easily be
Source: www.karger.comCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/c9Nu5wVomO
-
-
Mashup Score: 0
Introduction: Tislelizumab (anti-programmed cell death protein 1 antibody) showed preliminary antitumor activity and tolerability in patients with advanced solid tumors, including hepatocellular carcinoma (HCC). This study aimed to assess the efficacy and safety of tislelizumab in patients with previously treated advanced HCC. Methods: The multireg
Source: www.karger.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Global effort @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA proud to see featured @MSKLibrary: Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial https://t.co/RRxI36Bys9
-
-
Mashup Score: 1Leukocytosis During Lithium Carbonate Treatment - 2 year(s) ago
International Pharmacopsychiatry O’Connell Ralph A. Psychiatric Research Division, St. Vincent’s Hospital and Medical Center New York, N.Y., USA …
Source: www.karger.comCategories: Hem/Oncs, Latest HeadlinesTweet-
3/8 - The Evidence One 1970 report of 22 patients on lithium noted the following white blood cell counts (WBCs): ☞Pre-drug: 8,050 ☞On lithium: 10,100 Other series show that the WBC returns to baseline when lithium is stopped. https://t.co/0aacYCwVd1 https://t.co/MhnO6ZVqzR
-
-
Mashup Score: 3Estimating the Prevalence of Dementia in India Using a Semi-Supervised Machine Learning Approach - 2 year(s) ago
Introduction: Accurate estimation of dementia prevalence is essential for making effective public and social care policy to support individuals and families suffering from the disease. The purpose of this paper is to estimate the prevalence of dementia in India using a semi-supervised machine learning approach based on a large nationally representa
Source: www.karger.comCategories: General Medicine News, Latest HeadlinesTweet-
New #AI research reveals scale of #dementia in India @uniofsurrey https://t.co/emLZNEHp6D https://t.co/dfNlCwqP3l
-
-
Mashup Score: 7Establishing Minimal Clinically Important Difference in Sleep Outcomes after Spinal Cord Stimulation in Patients with Chronic Pain Disorders - 2 year(s) ago
Introduction: As one of the most common medical conditions for which patients seek medical care, chronic pain can be debilitating. The relationship between chronic pain and sleep is thought to be bidirectional, suggesting that treatment of one can be beneficial to the other. There is mounting evidence that spinal cord stimulation (SCS) improves asp
Source: www.karger.comCategories: General Medicine News, Latest HeadlinesTweet-
Study unravels interplay between sleep, #chronicpain and #spinalcordstimulation @FlaAtlanticU https://t.co/ubB0YB48Pe https://t.co/KK5g1xidOQ
-
-
Mashup Score: 5Structural Cerebral Network Differences in Prodromal Alzheimer’s Disease and Prodromal Dementia with Lewy Bodies - 2 year(s) ago
Introduction: Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) have long prodromal phases without dementia. However, the patterns of cerebral network alteration in this early stage of the disease remain to be clarified. Method: Participants were 48 patients with mild cognitive impairment (MCI) due to AD (MCI-AD), 18 patients with MCI wi
Source: www.karger.comCategories: Latest Headlines, NeurologyTweet-
“Structural Cerebral Network Differences in Prodromal Alzheimer’s Disease and Prodromal Dementia with Lewy Bodies” by Miho Ota et al. Dementia and Geriatric Cognitive Disorders https://t.co/wWD9p7T8Qn
-
-
Mashup Score: 1Structural Cerebral Network Differences in Prodromal Alzheimer’s Disease and Prodromal Dementia with Lewy Bodies - 2 year(s) ago
Introduction: Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) have long prodromal phases without dementia. However, the patterns of cerebral network alteration in this early stage of the disease remain to be clarified. Method: Participants were 48 patients with mild cognitive impairment (MCI) due to AD (MCI-AD), 18 patients with MCI wi
Source: www.karger.comCategories: General Medicine News, Latest HeadlinesTweet-
Predicting dementia using neural network characteristics @uoftsukuba https://t.co/OMhJgzvNDc https://t.co/Ni3QeZcNP8
-
-
Mashup Score: 0Mid-Childhood Outcomes after Dextrose Gel Treatment of Neonatal Hypoglycaemia: Follow-Up of the Sugar Babies Randomized Trial - 2 year(s) ago
Introduction: Dextrose gel is widely used as first-line treatment for neonatal hypoglycaemia given its cost-effectiveness and ease of use. The Sugar Babies randomized trial first showed that 40% dextrose gel was more effective in reversing hypoglycaemia than feeding alone. Follow-up of the Sugar Babies Trial cohort at 2 and 4.5 years of age reporte
Source: www.karger.comCategories: Latest Headlines, PediatricsTweet-
The Sugar Babies at 9-10 years. Dextrose gel and mid-childhood outcomes by St. Clair et al in Neonatology @WCHKarger https://t.co/yM2u6FUeuu #EBNeoAlerts #NeoEBM #neotwitter https://t.co/fYPYIgUN0w
-
-
Mashup Score: 0The Rationale and Evidence for SGLT2 Inhibitors as a Treatment for Nondiabetic Glomerular Disease - 2 year(s) ago
Background: Recent studies show that sodium-glucose cotransporter 2 inhibitors (SGLT2i), originally approved for glycemic control in patients with type 2 diabetes, also exert renoprotective effects independently from effects on dysglycemia. Moreover, recent work indicates that SGLT2i treatment may be effective in patients with nondiabetic chronic k
Source: www.karger.comCategories: Hem/Oncs, Latest HeadlinesTweet-
The Rationale and Evidence for SGLT2 Inhibitors as a Treatment for Nondiabetic Glomerular Disease - FullText - Glomerular Diseases 2021, Vol. 1, No. 1 - Karger Publishers https://t.co/LsAXkJJyTg
-
RT @EndoKarger: The History of #Obesity Research 🔗 https://t.co/bab3MF3W2b ✍ Nakamura S. et al. 📖 #HormResPaediatr #FreeAccess #Leptin #C…